Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion

European Urology
Christine ChevreauBernard Malavaud

Abstract

To report the long-term impact of two cycles of adjuvant chemotherapy on relapse rates and treatment-related morbidity in high-risk stage I nonseminomatous testicular germ cell tumors (NSGCTT I). From April 1987 to September 1997, 40 stage I NSGCTT patients with evidence of vascular invasion and/or embryonal carcinoma (EC) in the orchidectomy specimen were treated with two courses of bleomycin, cisplatin, and etoposide (BEP). All patients but one (incidental death) were alive after an extended follow-up (median 113.2 months, range 63-189). No patients relapsed but two patients presented a second cancer in the remaining testis. Short-term toxicity was minimal and no long-term toxicity was observed. The present series, with extensive follow-up, demonstrated that the efficacy and toxicity of two cycles of BEP compared well with the results of surveillance strategies or RPLND in high-risk stage I NSGCTT.

Citations

Mar 9, 2006·World Journal of Urology·Stephen D W Beck, Richard S Foster
Jul 29, 2009·World Journal of Urology·Dirk H Westermann, Urs E Studer
Nov 5, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J-L DevilleC Bastide
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X DurandUNKNOWN Oncology Committee of the French Association of Urology (CCAFU)
May 21, 2013·Asian Journal of Andrology·Zhao-Jie LvZhi-Ming Cai
Apr 9, 2005·Current Opinion in Oncology·Arif Hussain
Jun 17, 2014·Expert Review of Anticancer Therapy·Sumit Isharwal, Michael C Risk
Dec 3, 2015·Expert Opinion on Pharmacotherapy·Christoph OingCarsten Bokemeyer
Feb 4, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X DurandUNKNOWN Les membres du CCAFU
Dec 23, 2011·Actas urologicas españolas·P AlbersUNKNOWN European Association of Urology
Jun 3, 2011·European Urology·Peter AlbersUNKNOWN European Association of Urology
May 17, 2011·Hematology/oncology Clinics of North America·Thomas Powles
Apr 17, 2010·European Urology·Marianne BrydøyUNKNOWN Norwegian Urology Cancer Group III study group
Mar 17, 2009·The Journal of Urology·Stephen B WilliamsJerome P Richie
Sep 23, 2008·Critical Reviews in Oncology/hematology·D PectasidesG Aravantinos
Sep 26, 2006·European Urology·Peter Albers
May 9, 2007·The Urologic Clinics of North America·Toni K ChoueiriEric A Klein
Jul 29, 2015·The Urologic Clinics of North America·Evan Kovac, Andrew J Stephenson
Nov 5, 2010·Journal of the American Chemical Society·Rachel A Giroux, Sidney M Hecht
Nov 3, 2005·Journal of the National Cancer Institute·Marianne BrydøyOlav Dahl
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Torgrim TandstadOlbjørn Klepp
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald de Wit, Karim Fizazi
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan OldenburgSophie D Fosså
Dec 30, 2008·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Sandra SesekeFlorian Seseke
Jan 31, 2013·Korean journal of urology·Yu Seob Shin, Hyung Jin Kim
Oct 21, 2009·BJU International·David J Vaughn
Mar 9, 2019·Expert Opinion on Pharmacotherapy·Winfried AlsdorfChristoph Oing
May 18, 2018·Acta Oncologica·Marla Karine AmaranteMaria Angelica Ehara Watanabe
Dec 6, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Timothy GilliganLenora A Pluchino
May 29, 2018·Advances in Urology·Robert A Huddart, Alison M Reid
Jan 28, 2017·Indian Journal of Surgical Oncology·Puneet Ahluwalia, Gagan Gautam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.